Search research articles
Contact Us
Filters
Showing results (131-140 of 425) with videos related to
Page
of 43
Sort By:
Plos One
|
September 28, 2020
Radiofrequency ablation using internally cooled wet electrodes in bipolar mode for the treatment of recurrent hepatocellular carcinoma after locoregional treatment: A randomized prospective comparative study
Jae Won Choi, Jeong Min Lee, Dong Ho Lee, et al.
Journal of Clinical Medicine
|
May 13, 2023
Smoking Increases the Risk of Hepatocellular Carcinoma and Cardiovascular Disease in Patients with Metabolic-Associated Fatty Liver Disease
Jeong-Ju Yoo, Man Young Park, Eun Ju Cho, et al.
Plos Medicine
|
June 12, 2023
The association between alcohol consumption and the risk of hepatocellular carcinoma according to glycemic status in Korea: A nationwide population-based study
Eun Ju Cho, Goh Eun Chung, Jeong-Ju Yoo, et al.
Atherosclerosis
|
April 1, 2018
Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction
Goh Eun Chung, Jeong-Hoon Lee, Heesun Lee, et al.
Gut and Liver
|
May 7, 2019
Long-term Nucleotide Analogue Treatment Has Higher Levels of Renal Toxicities than Does Entecavir in Patients with Chronic Hepatitis B
Young Youn Cho, Young Chang, Joon Yeul Nam, et al.
Gut and Liver
|
September 5, 2025
Alternative Surveillance Improves Outcomes by Detecting Early-Stage Hepatocellular Carcinoma in Chronic Hepatitis B Patients
Dong Ho Lee, Heejin Cho, Su Jong Yu, et al.
Investigational New Drugs
|
December 8, 2018
Multicenter retrospective analysis of the safety and efficacy of regorafenib after progression on sorafenib in Korean patients with hepatocellular carcinoma
Changhoon Yoo, Joong-Won Park, Yoon Jun Kim, et al.
Gut and Liver
|
November 10, 2025
Prognostic Impact of Varices and Hemorrhagic Events in Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab
Jeayeon Park, Dong Ho Lee, Moon Haeng Hur, et al.
Journal of Korean Medical Science
|
July 18, 2023
Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study
Heejoon Jang, Su Jong Yu, Hong Ghi Lee, et al.
Frontiers in Medicine
|
December 30, 2021
Outcome of Initial Progression During Nivolumab Treatment for Hepatocellular Carcinoma: Should We Use iRECIST?
Dong Ho Lee, Sangyoun Hwang, Young Hwan Koh, et al.
Page
of 43
Search research articles
Search
Showing results (131-140 of 425) with videos related to
Sort By:
Page
of 43
Plos One
|
September 28, 2020
Radiofrequency ablation using internally cooled wet electrodes in bipolar mode for the treatment of recurrent hepatocellular carcinoma after locoregional treatment: A randomized prospective comparative study
Jae Won Choi, Jeong Min Lee, Dong Ho Lee, et al.
Journal of Clinical Medicine
|
May 13, 2023
Smoking Increases the Risk of Hepatocellular Carcinoma and Cardiovascular Disease in Patients with Metabolic-Associated Fatty Liver Disease
Jeong-Ju Yoo, Man Young Park, Eun Ju Cho, et al.
Plos Medicine
|
June 12, 2023
The association between alcohol consumption and the risk of hepatocellular carcinoma according to glycemic status in Korea: A nationwide population-based study
Eun Ju Cho, Goh Eun Chung, Jeong-Ju Yoo, et al.
Atherosclerosis
|
April 1, 2018
Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction
Goh Eun Chung, Jeong-Hoon Lee, Heesun Lee, et al.
Gut and Liver
|
May 7, 2019
Long-term Nucleotide Analogue Treatment Has Higher Levels of Renal Toxicities than Does Entecavir in Patients with Chronic Hepatitis B
Young Youn Cho, Young Chang, Joon Yeul Nam, et al.
Gut and Liver
|
September 5, 2025
Alternative Surveillance Improves Outcomes by Detecting Early-Stage Hepatocellular Carcinoma in Chronic Hepatitis B Patients
Dong Ho Lee, Heejin Cho, Su Jong Yu, et al.
Investigational New Drugs
|
December 8, 2018
Multicenter retrospective analysis of the safety and efficacy of regorafenib after progression on sorafenib in Korean patients with hepatocellular carcinoma
Changhoon Yoo, Joong-Won Park, Yoon Jun Kim, et al.
Gut and Liver
|
November 10, 2025
Prognostic Impact of Varices and Hemorrhagic Events in Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab
Jeayeon Park, Dong Ho Lee, Moon Haeng Hur, et al.
Journal of Korean Medical Science
|
July 18, 2023
Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study
Heejoon Jang, Su Jong Yu, Hong Ghi Lee, et al.
Frontiers in Medicine
|
December 30, 2021
Outcome of Initial Progression During Nivolumab Treatment for Hepatocellular Carcinoma: Should We Use iRECIST?
Dong Ho Lee, Sangyoun Hwang, Young Hwan Koh, et al.
Page
of 43